DUXAP8 and hepatocellular carcinoma: Considering that DUXAP8 is mainly localized in the cytoplasm, while RNA sequencing analysis and bioinformatics analysis also indicate that DUXAP8 has a putative binding site for miR-584-5p, it was therefore suspected that DUXAP8 also affects HCC progression through a ceRNA mechanism.